blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3270961

EP3270961 - MODULATION OF TUMOR IMMUNITY BY PROTEIN-MEDIATED O2 DELIVERY [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  12.04.2019
Database last updated on 15.11.2024
FormerRequest for examination was made
Status updated on  28.12.2017
FormerThe international publication has been made
Status updated on  04.11.2016
Most recent event   Tooltip28.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Omniox, Inc.
75 Shoreway Road
Suite B
San Carlos, CA 94070-2727 / US
[2018/04]
Inventor(s)01 / CARY, Stephen, P. L.
C/o Omniox, Inc.
75 Shoreway Road
Suite B
San Carlos, CA 94070-2727 / US
02 / KRTOLICA, Ana
C/o Omniox, Inc.
75 Shoreway Road
Suite B
San Carlos, CA 94070-2727 / US
03 / LE MOAN, Natacha
C/o Omniox, Inc.
75 Shoreway Road
Suite B
San Carlos, CA 94070-2727 / US
04 / WINGER, Jonathan, A.
C/o Omniox, Inc.
75 Shoreway Road
Suite B
San Carlos, CA 94070-2727 / US
05 / LEONG, Kevin, G.
C/o Omniox, Inc.
75 Shoreway Road
Suite B
San Carlos, CA 94070-2727 / US
 [2018/04]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2018/04]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date16734059.517.03.2016
[2018/04]
WO2016US22981
Priority number, dateUS201562134523P17.03.2015         Original published format: US 201562134523 P
[2018/04]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2016149562
Date:22.09.2016
Language:EN
[2016/38]
Type: A2 Application without search report 
No.:EP3270961
Date:24.01.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 22.09.2016 takes the place of the publication of the European patent application.
[2018/04]
Search report(s)International search report - published on:EP03.11.2016
ClassificationIPC:A61K39/39, A61K38/00, A61K38/16
[2018/04]
CPC:
A61K38/164 (EP,IL,KR,US); A61K39/39 (EP,IL,KR,US); A61K38/00 (RU);
A61K38/16 (RU); A61K45/06 (US); A61K47/60 (US);
A61P35/00 (EP,US); A61N2005/1098 (US); A61N5/10 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/04]
Extension statesBA05.10.2017
ME05.10.2017
Validation statesMA05.10.2017
MD05.10.2017
TitleGerman:MODULATION DER TUMORIMMUNITÄT DURCH PROTEIN-VERMITTELTE O2-FREISETZUNG[2018/04]
English:MODULATION OF TUMOR IMMUNITY BY PROTEIN-MEDIATED O2 DELIVERY[2018/04]
French:MODULATION DE L'IMMUNITÉ TUMORALE PAR PROTEINES MÉDIATRICES DE LA DÉLIVRANCE D'O2[2018/04]
Entry into regional phase05.10.2017National basic fee paid 
05.10.2017Designation fee(s) paid 
05.10.2017Examination fee paid 
Examination procedure05.10.2017Examination requested  [2018/04]
05.10.2017Date on which the examining division has become responsible
15.06.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
15.06.2018Despatch of communication of loss of particular rights: Claims {1}
24.08.2018Amendment by applicant (claims and/or description)
16.04.2019Despatch of a communication from the examining division (Time limit: M06)
24.10.2019Reply to a communication from the examining division
01.04.2020Despatch of a communication from the examining division (Time limit: M06)
07.10.2020Reply to a communication from the examining division
Request for further processing for:Loss of rights: Claims
24.08.2018Request for further processing filed
24.08.2018Full payment received (date of receipt of payment)
Request granted
19.09.2018Decision despatched
24.08.2018Request for further processing filed
24.08.2018Full payment received (date of receipt of payment)
Request granted
19.09.2018Decision despatched
24.08.2018Request for further processing filed
24.08.2018Full payment received (date of receipt of payment)
Request granted
19.09.2018Decision despatched
Fees paidRenewal fee
27.04.2018Renewal fee patent year 03
27.03.2019Renewal fee patent year 04
27.03.2020Renewal fee patent year 05
29.03.2021Renewal fee patent year 06
28.03.2022Renewal fee patent year 07
27.03.2023Renewal fee patent year 08
27.03.2024Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
31.03.201803   M06   Fee paid on   27.04.2018
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[I]US8404631  (CARY STEPHEN P L [US], et al) [I] 1-8,12-48,52-114,118-141 * table 2 * * column 33; table 3 * * column 37, paragraph middle ** column 50, paragraph l *;
 [XI]WO2014107171  (OMNIOX INC [US]) [X] 1-8,12-31,33,37-48,52-71,73,77-114,118-141 * examples 5-7 * * paragraph [0221] * [I] 32,34-36,72,74-76
by applicant   - CODO ET AL., ONCOTARGET, (2014), vol. 5, no. 17, pages 7651 - 7662
    - LEE, MACE; REPASKY, INT J HYPERTHERMIA, (2010), vol. 26, no. 3, pages 232 - 246
    - WEI ET AL., PLOS ONE, (2011), vol. 6, no. 1, page E16195
    - NOMAN ET AL., J EXP MED, (2014), vol. 211, no. 5, pages 781 - 790
    - OHTA ET AL., PROC NATL ACAD SCI USA, (2006), vol. 103, no. 35, pages 13132 - 13137
    - CHATURVEDI ET AL., PROC NATL ACAD SCI USA, (2014), vol. 111, no. 20, pages E2120 - E2129
    - CORZO ET AL., J EXP MED, (2010), vol. 207, no. 11, pages 2439 - 2453
    - SIEMENS ET AL., CANCER RES, (2008), vol. 68, no. 12, pages 4746 - 4753
    - MIMURA ET AL., J PHARMACOL SCI, (2011), vol. 115, no. 4, pages 453 - 458
    - HATFIELD ET AL., SCI TRANSL MED, (2015), vol. 7, no. 277, page 277RA230
    - OVERGAARD, J CLIN ONCOL, (2007), vol. 25, no. 26, pages 4066 - 4074
    - IYER; LM ET AL., BMC GENOMICS, (2003), vol. 4, no. 1, page 5
    - KAROW, DS ET AL., BIOCHEMISTRY, (2004), vol. 43, no. 31, pages 10203 - 10211
    - BOON, EM ET AL., NATURE CHEM. BIOL., (2005), vol. 1, pages 53 - 59
    - BOON, EM ET AL., CURR. OPIN. CHEM. BIOL., (2005), vol. 9, no. 5, pages 441 - 446
    - BOON, EM, J. INORG. BIOCHEM., (2005), vol. 99, no. 4, pages 892 - 902
    - CARY, SP ET AL., PROC NATL ACAD SCI USA, (2005), vol. 102, no. 37, pages 13064 - 9
    - KAROW DS ET AL., BIOCHEMISTRY, (2005), vol. 44, no. 49, pages 16266 - 74
    - CARY, SP ET AL., TRENDS BIOCHEM SCI, (2006), vol. 31, no. 4, pages 231 - 239
    - BOON, EM ET AL., J BIOL CHEM, (2006), vol. 281, no. 31, pages 21892 - 21902
    - WINGER, JA ET AL., J BIOL CHEM., (2007), vol. 282, no. 2, pages 897 - 907
    - PELLICENA, P. ET AL., PROC NATL. ACAD SCI USA, (2004), vol. 101, no. 35, pages 12854 - 12859
    - OUELLET, H., PROC. NATL. ACAD. SCI. U S A, (2002), vol. 99, no. 9, pages 5902 - 5907
    - IYER, L. M. ET AL., BMC GENOMICS, (20030203), vol. 4, no. 1, page 5
    - KAROW, D. S. ET AL., BIOCHEMISTRY, (20040810), vol. 43, no. 31, pages 10203 - 10211
    - BOON, E. M ET AL., NATURE CHEM. BIOL., (2005), vol. 1, pages 53 - 59
    - BOON, E. M. ET AL., CURR. OPIN. CHEM. BIOL., (200510), vol. 9, no. 5, pages 441 - 446
    - BOON, E. M. ET AL., J. INORG. BIOCHEM., (2005), vol. 99, no. 4, pages 892 - 902
    - BOON, E. M. ET AL., NATURE CHEMICAL BIOLOGY, (2005), vol. 1, pages 53 - 59
    - BOON E.M. ET AL., NATURE CHEMICAL BIOLOGY, (2005), vol. 1, pages 53 - 59
    - PELLICENA, P. ET AL., PROC NATL. ACAD SCI USA, (20040831), vol. 101, no. 35, pages 12854 - 12859
    - ROHLFS, R. J. ET AL., J. BIOL. CHEM., (19980515), vol. 273, no. 20, pages 12128 - 12134
    - MIGITA, R ET AL., J. APPL. PHYSIOL., (199706), vol. 82, no. 6, pages 1995 - 2002
    - VANDEGRIFF, K. D. ET AL., BIOCHEM J., (20040815), vol. 382, pages 183 - 189
    - EFIMOV, V. P. ET AL., J MOL BIOL, (1994), vol. 242, pages 470 - 486
    - BOUDKO, S. P. ET AL., EUR J BIOCHEM, (2002), vol. 269, pages 833 - 841
    - LETAROV, A. V. ET AL., BIOCHEMISTRY (MOSC, (1999), vol. 64, pages 817 - 823
    - TAO, Y. ET AL., STRUCTURE, (1997), vol. 5, pages 789 - 798
    - YANG, X ET AL., J VIROL, (2002), vol. 76, pages 4634 - 4642
    - PAPANIKOLOPOULOU, K. ET AL., J BIOL CHEM, (2004), vol. 279, pages 8991 - 8998
    - PAPANIKOLOPOULOU, K ET AL., J MOL BIOL, (2004), vol. 342, pages 219 - 227
    - ZHANG, C. ET AL., BIOTECHNOL PROG, (2009), vol. 25, pages 1660 - 1668
    - BHARDWAJ, A. ET AL., PROTEIN SCI, (2008), vol. 17, pages 1475 - 1485
    - SISSOEFF, L. ET AL., J GEN VIROL, (2005), vol. 86, pages 2543 - 2552
    - GUTHE, S. ET AL., J MOL BIOL, (2004), vol. 337, pages 905 - 915
    - STETEFELD, J ET AL., STRUCTURE, (2003), vol. 11, pages 339 - 346
    - YOKOI, N. ET AL., SMALL, (2010), vol. 6, pages 1873 - 1879
    - BHARDWAJ, A. ET AL., J MOL BIOL, (2007), vol. 371, pages 374 - 387
    - DU, C. ET AL., APPL MICROBIOL BIOTECHNOL, (2008), vol. 79, pages 195 - 202
    - BOON, E. M. ET AL., NATURE CHEM. BIOL., (2005), vol. 1, pages 53 - 59
    - BOON, E. M ET AL., CURR. OPIN. CHEM. BIOL., (200510), vol. 9, no. 5, pages 441 - 446
    - VANDEGRIFF, K. D ET AL., BIOCHEM J., (20040815), vol. 382, pages 183 - 189
    - BOBOFCHAK, K. M. ET AL., AM. J. PHYSIOL. HEART CIRC. PHYSIOL., (200308), vol. 285, no. 2, pages H549 - H561
    - BOON, E.M. ET AL., NATURE CHEMICAL BIOLOGY, (2005), vol. 1, pages 53 - 59
    - DMOCHOWSKI, 1. J. ET AL., J INORG BIOCHEM., (20000831), vol. 81, no. 3, pages 221 - 228
    - GUARNONE, R. ET AL., HAEMATOLOGICA, (199509), vol. 80, no. 5, pages 426 - 430
    - LEE; MACE; REPASKY, INT J HYPERTHERMIA,, (2010), vol. 26, no. 3, pages 232 - 246
    - WEI ET AL., PL S ONE, (2011), vol. 6, no. 1, page E16195
    - KALLET; MATTHAY, RESPIR CARE, (2013), vol. 58, no. 1, pages 123 - 141
    - THIEL ET AL., PLOS BIOL, (2005), vol. 3, no. 6, page E174
    - LEWIS; HUGHES, BREAST CANCER RES, (2007), vol. 9, no. 3, page 209
    - FANG ET AL., BLOOD, (2009), vol. 114, no. 4, pages 844 - 859
    - TAKEDA ET AL., GENES DEV, (2010), vol. 24, no. 5, pages 491 - 501
    - DEMARIA ET AL., INT J RADIAT ONCOL BIOL PHYS, (2005), vol. 63, no. 3, pages 655 - 666
    - BROWN, INT J RADIAT BIOL, (2010), vol. 86, no. 11, pages 907 - 917
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.